CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma.
Li Z, Ju X, Lee K, Clarke C, Hsu JL, Abadir E, Bryant CE, Pears S, Sunderland N, Heffernan S, Hennessy A, Lo TH, Pietersz GA, Kupresanin F, Fromm PD, Silveira PA, Tsonis C, Cooper WA, Cunningham I, Brown C, Clark GJ, Hart DNJ
Progression of the first stage of spontaneous labour: A prospective cohort study in two sub-Saharan African countries.
Oladapo OT, Souza JP, Fawole B, Mugerwa K, Perdoná G, Alves D, Souza H, Reis R, Oliveira-Ciabati L, Maiorano A, Akintan A, Alu FE, Oyeneyin L, Adebayo A, Byamugisha J, Nakalembe M, Idris HA, Okike O, Althabe F, Hundley V, Donnay F, Pattinson R, Sanghvi HC, Jardine JE, Tunçalp Ö, Vogel JP, Stanton ME, Bohren M, Zhang J, Lavender T, Liljestrand J, Ten Hoope-Bender P, Mathai M, Bahl R, Gülmezoglu AM